SEC Form 4 · accession 0001457612-18-000013
GENOCEA BIOSCIENCES, INC. · GNCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jessica Baker Flechtner
Officer — Chief Scientific Officer
Period of report
Feb 8, 2018
Accepted (ET)
Feb 12, 2018 · 8:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001457612
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.98 | Feb 8, 2018 | A | 137,500 | A | — | Feb 7, 2028 | Common Stock | 137,500 | 137,500 | D |
Explanation of responses
- F1The options granted will vest annually in 48 equal monthly installments beginning on the first monthly anniversary of the grant date. The Company's Board of Directors also approved on February 8, 2018 that, subject to stockholder approval, Jessica Baker Flechtner will receive 162,500 additional options with the same grant date, at the same exercise price and pursuant to the same vesting schedule.